机构：[1]Hepato-Pancreato-Biliary Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.[2]Department of Surgical Oncology, Qin Huai Medical District of Jinling Hospital, Nanjing University, Nanjing, China.[3]Department of Hepatobiliary and Pancreatic Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Hangzhou, China.浙江省肿瘤医院[4]Department of Hepatic Surgery II, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.[5]Department of Hepatobiliary Surgery, General Hospital of Northern Theater Command, Shenyang, China.[6]Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China.[7]Interventional Radiology Department, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.[8]Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai, China.[9]Department of Medical Oncology of PLA Cancer Center, Jinling Hospital, Nanjing, China.[10]Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.[11]Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.[12]Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Institute of Pathology and Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.[13]Department of General Surgery, Zibo Central Hospital, Zibo, China.[14]Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, China.[15]Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.[16]Department of Hepatobiliary, The Second Affiliated Hospital of Army Medical University, Chongqing, China.[17]Department of General Surgery, Jiangxi Provincial Clinical Research Center for General Surgery Disease, The Second Affiliated Hospital of Nanchang University, Nanchang, China.[18]Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.[19]Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, China.[20]Department of Interventional Radiology, Maanshan People's Hospital, Maanshan, China.[21]Department of Oncology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.[22]Hepatobiliary Center, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Liver Transplantation, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.江苏省人民医院[23]Department of Hepatic Surgery VI, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.[24]Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.[25]Zhongda Hospital, School of Life Sciences and Technology, Advanced Institute for Life and Health, Southeast University, Nanjing, China.[26]Department of Surgery, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.[27]Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, China.[28]Liver Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.[29]Department of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Jiangsu Provincial Key Research and
Development Program, Grant/Award
Number: BE2019747; National Natural
Science Foundation of China, Grant/
Award Number: 81871988, 82002584 and
82103009
第一作者机构：[1]Hepato-Pancreato-Biliary Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
共同第一作者：
通讯作者：
通讯机构：[1]Hepato-Pancreato-Biliary Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.[23]Department of Hepatic Surgery VI, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.[28]Liver Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.[29]Department of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.[*1]Hepato-PancreatoBiliary Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China[*2]Department of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai 200438, China[*3]Department of Hepatic Surgery VI, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.[*4]Liver Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
推荐引用方式(GB/T 7714)：
Lei Zhengqing,Ma Weihu,Si Anfeng,et al.Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma[J].ALIMENTARY PHARMACOLOGY & THERAPEUTICS.2023,58(6):611-622.doi:10.1111/apt.17623.
APA：
Lei Zhengqing,Ma Weihu,Si Anfeng,Zhang Yuhua,Yang Facai...&Cheng Zhangjun.(2023).Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.ALIMENTARY PHARMACOLOGY & THERAPEUTICS,58,(6)
MLA：
Lei Zhengqing,et al."Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma".ALIMENTARY PHARMACOLOGY & THERAPEUTICS 58..6(2023):611-622
医学